» Articles » PMID: 3596812

[Lipoid A Antibody Titer in the Human]

Overview
Journal Infection
Date 1987 Mar 1
PMID 3596812
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Lipid A is the toxic component of endotoxin in gram-negative bacteria. Antibodies to lipid A are not usually found in healthy persons (or only at a low titer) without a corresponding history of infection. Even gram-negative septicemia is found to be accompanied by only low titers. A completely different situation is seen in patients with chronic or recurrent infections due to Enterobacteriaceae and other gram-negative bacteria. Here it is notable that the antibody titer varies with the type of disorder (e.g. cystitis and pyelonephritis). A severe wound infection, e.g. due to Pseudomonas aeruginosa, also leads to measurable lipid A antibody titers. Varying antibody titers can be observed in cystic fibrosis, Crohn's disease, and severe surgical infections. One can conclude that a significantly elevated antibody titer develops during an extensive tissue involvement of long duration and indeed is caused by tissue inhibition by endotoxin. Based on clinical experience, it can be assumed that lipid A antibodies present in the body have a protective effect in septic shock.

Citing Articles

Endotoxin neutralization as a biomonitor for inflammatory bowel disease.

Champion K, Chiu L, Ferbas J, Pepe M PLoS One. 2013; 8(6):e67736.

PMID: 23826338 PMC: 3691319. DOI: 10.1371/journal.pone.0067736.


Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.

Kronborg G, Pressler T, Fomsgaard A, Koch C, Hoiby N Infection. 1993; 21(5):297-302.

PMID: 8300245 DOI: 10.1007/BF01712448.


ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens.

Freudenberg M, Fomsgaard A, Mitov I, Galanos C Infection. 1989; 17(5):322-8.

PMID: 2689350 DOI: 10.1007/BF01650719.

References
1.
Mar P, Marget W, Schneider K, Belohradsky B, Roos R . Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study. Eur J Pediatr. 1987; 146(1):51-5. DOI: 10.1007/BF00647284. View

2.
Marget W, Mar P, Jaspers L, Possinger K, Haslberger H . Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection. 1985; 13(3):120-4. DOI: 10.1007/BF01642870. View

3.
Marget W, Weiss M, Ruhland B . Lipid A antibody determinations using ELISA on patients at a children's hospital: a preliminary report. Infection. 1983; 11(2):84-6. DOI: 10.1007/BF01641072. View

4.
Schussler P, Kruis W, Marget W . [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)]. Med Klin. 1976; 71(44):1898-902. View

5.
Simon G, Reindke B, Marget W . [Lipid A antibody titers in pyelonephritis and other gram-negative infections (author's transl)]. Infection. 1974; 2(4):178-84. DOI: 10.1007/BF01641457. View